US Patent 7989188 Conjugates for cancer therapy and diagnosis
Patent 7989188 was granted and assigned to Biosight Ltd. on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+487 characters)
Article
Patent abstract
The present invention relates to conjugates of a drug and an amino acid or an amino acid derivative or analog, pharmaceutical compositions that include the conjugates and methods of use thereof. In particular, the present invention relates to conjugates of anti-proliferative drugs and asparagine and glutamine and analogs thereof as compositions for treatment of cancer, and conjugates of imaging agent carriers and amino acids for the diagnosis of tumors and metastases.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Esther Izakovich0
Stela Gengrinovitch0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07989188 Conjugates for cancer therapy and diagnosis US Patent 7989188 Conjugates for cancer therapy and diagnosis
Infobox
Patent Number
07989188
Patent Number
7989188
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07989188 Conjugates for cancer therapy and diagnosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07989188
Date of patent
August 2, 2011
Patent application number
11497511
Date Filed
August 2, 2006
Patent primary examiner
Find more entities like US Patent 7989188 Conjugates for cancer therapy and diagnosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
